Previous 10 | Next 10 |
Atossa Therapeutics (NASDAQ: ATOS) got off to a roaring start this week, with its stock closing just over 30% higher on Monday to reach a new one-year peak. The company announced that clinical results for a promising pipeline drug are coming in a matter of days. Atossa, a clinic...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in Atossa Therapeutics (NASDAQ: ATOS ) and ATOS stock are seeing a lot of green. Shares of ATOS stock are up approximately 27% at the time of writing on very heavy volume. Source: Shutte...
These Former Penny Stocks Are Surging In June & AMC Stock May’ve Helped When it comes to penny stocks, no others have clearly demonstrated the potential better than AMC stock & GameStop. This year has been one for the record books. While 2020 was all about recovery an...
Photo by Igor Kutyaev/iStock via Getty Images Atossa Therapeutics ([[ATOS]] +25.8%) has reached the highest level since March 2019 after the company announced an upcoming data readout from a key development program targeting patients with breast cancer before surgery. The webinar is sche...
Gainers: Ra Medical Systems RMED +54%, Liminal BioSciences LMNL +42%, Atossa Therapeutics (ATOS) +27%, Bionano Genomics BNGO +20%, Clover Health Investments (CLOV) +16%.Losers: Cabaletta Bio (CABA) -10%, MacroGenics (MGNX) -8%, Purple Bio...
SEATTLE, June 07, 2021 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in oncology and infectious disease with a current focus on breast cancer and COVID-19, announces that it will ...
3 Hot Penny Stocks on Reddit For Summer 2021 As Summer comes on fast, penny stocks are heating up. While typically, the Summer is a time when the market slows down in volume, access to trading platforms like Robinhood could mean that this is a thing of the past. And, with the major infl...
Atossa Therapeutics (NASDAQ: ATOS) stock closed just over 20% higher on Tuesday. The surge was due to a modest but impactful price target raise from an analyst tracking the company. Prognosticator Edward Woo lifted said price target on Atossa to an even $8 per share from the pre...
New Research Demonstrates Claims that the Wuhan Institute of Virology had no cases of COVID-19 are not credible PR Newswire SEATTLE , May 27, 2021 /PRNewswire/ -- DRASTIC Investigator Gilles Demaneuf and Physician-Scientist Dr. Steven C. Quay , M.D.,...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s another busy day of trading and where would we be without Reddit rising interest in various penny stocks? It’s become a normal trend at this point and we’re following up on it by checking out the p...
News, Short Squeeze, Breakout and More Instantly...
Atossa Therapeutics Inc. Company Name:
ATOS Stock Symbol:
NASDAQ Market:
Atossa Therapeutics Inc. Website:
SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the Phase 2 EVANGELINE (Endoxifen Versus exemestANe GosEreLIn) study has fully...